DC/PC3 Dendritic Cell Vaccine

dendritic cell vaccine loaded with PC3 prostate cancer cells (DC/PC3) · Rockefeller University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DC/PC3 Dendritic Cell Vaccine, covering 2016-04-18 to 2016-04-18. Get the full timeline:

Most recent: Clinical Trial Update: Dendritic Cell Vaccine Study (DC/PC3) for Prostate Cancer [Phase 1, Phase 2]